Clinical trial ELEVATE
A Phase 1b/2, Open-label Umbrella Study to Evaluate Safety and Efficacy of Elacestrant in Various Combinations in Patients with Metastatic Breast Cancer (ELEVATE) (STML-ELA-0222d)
| Cancers | |
|---|---|
| Organ | Breast |
| Trial status | Trial open for recruitment |
| Investigator | |
| Trial type |
Interventional with experimental drug
|
| Phase | Trial phase 1/2 |
| Academic trial | Non |
| Sponsor | Stemline Therapeutics, Inc. |
| EudraCT Identifier | 2022-503114-23-00 |
| ClinicalTrials.gov | https://clinicaltrials.gov/ct2/show/NCT05563220 |
| Last update |